Pei-Qi Liu

Title: Pei-Qi Liu: Innovator in Genetic Research

Introduction

Pei-Qi Liu is a prominent inventor based in Richmond, CA (US). She has made significant contributions to the field of genetic research, particularly in the development of methods and compositions for treating various genetic disorders. With a total of 8 patents to her name, Liu's work has the potential to impact many lives.

Latest Patents

Among her latest patents are innovative methods and compositions for the treatment of beta thalassemia. These advancements provide new avenues for addressing this genetic condition. Additionally, she has developed methods and compositions for inactivating glutamine synthetase gene expression. This patent discloses the use of fusion proteins that comprise a zinc finger protein and a cleavage domain or cleavage half-domain, along with polynucleotides encoding these fusion proteins.

Career Highlights

Pei-Qi Liu has worked with notable companies in the biotechnology sector, including Sangamo Biosciences, Inc. and Sangamo Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.

Collaborations

Throughout her career, Liu has collaborated with esteemed colleagues such as Edward J. Rebar and Andrew Jamieson. These partnerships have further enhanced her research capabilities and contributed to her success as an inventor.

Conclusion

Pei-Qi Liu's innovative work in genetic research exemplifies her dedication to advancing medical science. Her patents and collaborations reflect her commitment to finding solutions for genetic disorders. Liu continues to be a significant figure in her field, paving the way for future innovations.